tiprankstipranks
Eli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss
PremiumThe FlyEli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss
2d ago
Lilly’s muvalaplin lowered lipoprotein(a) levels in adults in Phase 2 trial
Premium
The Fly
Lilly’s muvalaplin lowered lipoprotein(a) levels in adults in Phase 2 trial
3d ago
Eli Lilly sues to change hospital drug discount payments, WSJ reports
Premium
The Fly
Eli Lilly sues to change hospital drug discount payments, WSJ reports
6d ago
Eli Lilly announces results from Phase 3 SURMOUNT-1 three-year study
PremiumThe FlyEli Lilly announces results from Phase 3 SURMOUNT-1 three-year study
8d ago
Market-Beating SCHG ETF: Simple and Effective Exposure to U.S. Growth Stocks
Premium
Market News
Market-Beating SCHG ETF: Simple and Effective Exposure to U.S. Growth Stocks
8d ago
Needham biotech analysts hold an analyst/industry conference call
Premium
The Fly
Needham biotech analysts hold an analyst/industry conference call
10d ago
AstraZeneca oral GLP1 looks to be trailing Eli Lilly’s, says Deutsche Bank
PremiumThe FlyAstraZeneca oral GLP1 looks to be trailing Eli Lilly’s, says Deutsche Bank
17d ago
AstraZeneca says experimental obesity pill ‘competitive,’ Bloomberg reports
Premium
The Fly
AstraZeneca says experimental obesity pill ‘competitive,’ Bloomberg reports
17d ago
Eli Lilly price target lowered to $1,015 from $1,025 at Deutsche Bank
Premium
The Fly
Eli Lilly price target lowered to $1,015 from $1,025 at Deutsche Bank
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100